Cargando…

A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases

OBJECTIVES: To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected or not to treatment modifications during vaccination. METHODS: A nationwide, multicenter study, including 605 SAARD patients an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzioufas, Athanasios G., Bakasis, Athanasios-Dimitrios, Goules, Andreas V., Bitzogli, Kleopatra, Cinoku, Ilir I., Chatzis, Loukas G., Argyropoulou, Ourania D., Venetsanopoulou, Aliki I., Mavrommati, Maria, Stergiou, Ioanna E., Pezoulas, Vasilis, Voulgari, Paraskevi V., Katsimpari, Chaido, Katechis, Spyridon, Gazi, Souzana, Katsifis, Gkikas, Sfontouris, Charalampos I., Georgountzos, Athanasios I., Liossis, Stamatis-Nick, Papagoras, Charalampos, Fotiadis, Dimitrios I., Skopouli, Fotini N., Vlachoyiannopoulos, Panayiotis G., Moutsopoulos, Haralampos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552665/ https://www.ncbi.nlm.nih.gov/pubmed/34757289 http://dx.doi.org/10.1016/j.jaut.2021.102743

Ejemplares similares

Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
por: Bakasis, Athanasios‐Dimitrios, et al.
Publicado: (2022)

Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective study
por: Sfikakis, Petros P., et al.
Publicado: (2023)

A computational workflow for the detection of candidate diagnostic biomarkers of Kawasaki disease using time-series gene expression data
por: Pezoulas, Vasileios C., et al.
Publicado: (2021)

Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases
por: Argyropoulou, Ourania D., et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece
por: Vlachoyiannopoulos, Panayiotis, et al.
Publicado: (2020)

Sjögren’s Syndrome: The Clinical Spectrum of Male Patients
por: Chatzis, Loukas, et al.
Publicado: (2020)

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
por: Alexopoulos, Harry, et al.
Publicado: (2020)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development
por: Goules, Andreas V., et al.
Publicado: (2020)

Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
por: Panagopoulos, Panagiotis K., et al.
Publicado: (2022)

Patient with ankylosing spondylitis and scleroderma renal crisis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2018)

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies
por: Boutzios, Georgios, et al.
Publicado: (2022)

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
por: Boutzios, Georgios, et al.
Publicado: (2023)

Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients
por: Kampylafka, Eleni I., et al.
Publicado: (2013)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021)

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
por: Laskari, Katerina, et al.
Publicado: (2011)

DNA Methylation Studies in Saliva of Patients with Sjögren’s Syndrome
por: Karagianni, Panagiota, et al.
Publicado: (2021)

Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment
por: Agryropoulou, Ourania, et al.
Publicado: (2018)

Bronchus-associated lymphoid tissue lymphoma (BALT) in a patient with primary Sjögren’s syndrome
por: Mole, Evangelia N., et al.
Publicado: (2017)

Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients
por: Papageorgiou, Aristea, et al.
Publicado: (2015)

Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
por: Panagopoulos, Panagiotis, et al.
Publicado: (2021)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren’s Syndrome
por: Stergiou, Ioanna E., et al.
Publicado: (2022)

Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
por: Kosmidis, Michalis L., et al.
Publicado: (2019)

Single Nucleotide Polymorphisms of Toll-like Receptor 4 in Hepatocellular Carcinoma—A Single-Center Study
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren’s Syndrome
por: Chatzis, Loukas, et al.
Publicado: (2021)

Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
por: Tektonidou, Maria G., et al.
Publicado: (2020)

COVID-19 Immunobiology: Lessons Learned, New Questions Arise
por: Kaklamanos, Aimilios, et al.
Publicado: (2021)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
por: Nezos, Adrianos, et al.
Publicado: (2021)

Book Review: Rheumatology in Questions
por: Tzioufas, Athanasios G.
Publicado: (2020)

Medical data sharing, harmonization and analytics
por: Fotiadis, Dimitrios I, et al.
Publicado: (2020)

Complex Regional Pain Syndrome: An update
por: Misidou, Christina, et al.
Publicado: (2019)

Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015)

SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tolflmbi71c5jlcikniebu53k2